Garuda - Garba Rujukan Digital

Article Per Year (5 Year)

All

Indonesian Journal of Obstetrics and Gynecology (Majalah Obstetri dan Ginekologi Indonesia)

journal
Website

Published by Perkumpulan Obstetri dan Ginekologi Indonesia

ISSN : 23386401 EISSN : 23387335 DOI : -

Core Subject : Health,

Health Professions Medicine & Pharmacology Public Health

The Indonesian Journal of Obstetrics and Gynecology is an official publication of the Indonesian Society of Obstetrics and Gynekology. INAJOG is published quarterly.

Arjuna Subject : -

Articles 21 Documents

1 2 3

Search results for , issue " Volume. 3, no. 2, April 2015" : 21 Documents clear

Modification of Immediate Postplacenta CuT-380A IUD Insertion Using Ring Forceps and Standard Inserter: Twelve Months Follow-up Tjahjanto, Hary; Hadiningrat, Wijoyo
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To evaluate the outcome of CuT-380A IUD postplacental insertion in vaginal delivery using new modification insertion technique. Method: We carried out a prospective cohort study of postplacental IUD insertion by means of ’push and push’ technique, using ring forceps and standard inserter (inserter tube and plunger rod). We included women who underwent vaginal delivery from 1st June 2009 until 31st March 2011 and had postplacental IUD insertion. Followup was conducted for 12 months, including history, physical examination, ultrasound and questionnaires during evaluation, through home visits and by phone. The first monitoring is before 6 weeks after delivery, the second monitoring was after 6 weeks up to 3 months, the third is after 3 months up to 6 months, the fourth is after 6 months up to 12 months, the fifth is after 12 months up to 24 months and the sixth is after 24 months up to 32 months after insertion. Result: On the second monitoring, 2 acceptors experienced expulsion. At the third monitoring period, one acceptor requested for IUD removal. At 9 months up to 12 months post-insertion, one expulsion was encountered, and one acceptor requested removal of device. At ≥12 months there was one acceptor who had IUD removal. We did not find any report of unintended pregnancy or perforation. Conclusion: Immediate post-placental insertion of CuT-380A IUD after vaginal delivery using ’push and push’ technique is safe and effective. The pregnancy rate at typical use is 0%, continuation rate is 94.1% and low expulsion rate (2.86%). Loss of follow up was 5.6% and no perforation was reported. Keywords: continuation rate, immediate post-placental IUD insertion, ’push and push’ technique, typical use, vaginal delivery

A Real-time Optoelectronic Device in Screening of Precancerous Cervical Lesion Rahmadhany, Rizky; Indarti, Junita
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To obtain the diagnostic values of optoelectronic device for screening of precancerous cervical lesions. Method: We performed a diagnostic study with cross sectional design. Subjects were recruited from Dr. Cipto Mangunkusumo Hospital, from February until December 2013. Subjects were enrolled based on consecutive sampling until the minimum sample was achieved (60 samples). Result: During the study period, 60 patients were enrolled. Sensitivity, specificity, positive predictive value, and negative predictive value of the optoelectronic device were 76%, 95%, 96%, and 64%, respectively. We also investigated diagnostic values of other screening methods, namely citology and colposcopy. Sensitivity and specificity of liquid based cytology were 83% and 63% respectively. The combination of optoelectronic device and liquid based cytology increased the sensitivity to 92.8%. Meanwhile, sensitivity and specificity of colposcopy were 88% and 58%, respectively. Based on Altman criteria, kappa value for optoelectronic device with cytology was 0.35 (fair) and optoelectronic device with colposcopy was 0.45 (moderate). Conclusion: A real-time optoelectronic device might be used as an alternative method in early detection of precancerous cervical lesions, either as a single method or combined with liquid based cytology. Keywords: diagnostic values, optoelectronic device, precancerous cervical lesions

A Red Card for Plagiarism Gunardi, Eka R
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

N/A

CC-Human Menopausal Gonadotropin Combined with Growth Hormone in Mini-stimulation Protocol could Improve Clinical Outcome in Poor Ovarian Responders Polim, Arie A; Sini, Ivan R; Anwar, Indra NC; Pradana, Aryando; Kurniawati, Kurniawati; Fani, Erliana
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To investigate the role of CC-highly purified Human Menopausal Gonadotropin (hpHMG) and Growth Hormone (GH) in mini-stimulation protocol to improve outcome in poor ovarian responders (POR). Method: All patients were given clomiphene citrate 150 mg from day 3 to day 7 of menstrual cycle followed by 150 IU hpHMG daily from day 8 until ovulation trigger. Two groups were observed where one group received GH and the other arm did not. In the GH group, 8 IU of GH were given from day 1 of stimulation until stimulation was stopped. GnRH antagonist was used to suppress ovulation. Result: Among 51 eligible women, 29 patients with GH and 22 patients without GH, no difference was observed in the number of oocytes retrieved (2.21 versus 2.64) and the number of embryos transferred (1.24 versus 1.68) in the GH group versus the group without GH, respectively. Total clinical pregnancy rate was 17.6%. No significant difference in pregnancy and ongoing pregnancy rate in both groups (17.2% versus 18.2%) and (13.8% versus 13.6%), respectively. In patients older than 40 years old, GH showed a 4-fold likelihood in producing top quality embryos (44.8% vs 13.6%, OR=3.6, p=0.05). Conclusion: CC-HMG regimen in mini-stimulation protocol is an effective option in poor responders. Additional GH in ministimulation program provided a higher number of top quality embryos in women older than 40 years old, although there were no difference in clinical or ongoing pregnancy rate. Keywords: CC-HMG, growth hormone, IVF, mini-stimulation protocol, poor ovarian responders

Factors Affecting Selection of Contraceptive Methods and Its Length of Use Astato, Erdiyan; Djajadilaga, Djajadilaga
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To evaluate the factors related to the selection of contraceptive methods and length of use on acceptors in Raden Saleh Clinic and Fatmawati General Hospital. Method: The study was a prospective observational study designs. The factors that we observed include the family planning factor (wife age, number of desired children and infertility), subjective factors (side effect experience of contraception, support from the husband/ family, and religion), objective factors (medical disorders, person helping to select contraception, family planning service centre and availability of contraceptives) and the level of motivation (level of education). All the clients who will receive contraception and meet the criteria for the research were interviewed and given questionnaires until the desired sample size is achieved. The study was conducted at the Raden Saleh Clinic and Fatmawati General Hospital. We then conducted follow-up at 3 and 6 months after the use of the contraceptive methods to assess the length of use. Result: The total number of subjects was 151 people. The average age of respondents was 31 years old, with the contraception options being IUD (67.1%), implants (17.8%), sterilization (7.2%), injectable contraception (3.9%), and oral contraception (3.9%). From all the factors studied, only the number of desired children were found to affect the selection of contraceptive methods significantly (p=0.008) in Fatmawati General Hospital, while in Raden Saleh Clinic all of the factors did not affect the selection of contraceptive method (p>0.05). We also found that all of these factors do not have a significant relationship to the length of contraceptive use (p>0.05). There were 6.6% of subjects (n=10) who switched the type of contraception. From all of them, there was a trend of switching from oral contraceptive to injectable method (33.3%) and from IUD to injectable method (66.7%). Conclusion: Only the number of desired children has an effect on the selection of contraceptive methods in Fatmawati General Hospital, while in Raden Saleh Clinic all of the factors studied do not affect in selection of contraceptive methods. Family planning factors, subjective factors, objective factors and motivation levels have no effect on the length of contraceptive use by clients at Raden Saleh Clinic and Fatmawati General Hospital. Keywords: contraception methods, factors, length of use, selection

Difference of Vertical Transmission in HIV-Infected Women with Complete and Incomplete PMTCT Fausihar, Sitti; Saroyo, Yudianto B
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To analyze any differences on vertical transmission in groups with complete and incomplete program as well as the factors influencing completion. Method: This was a retrospective cohort study performed by data collection from medical records and/or interviews from January 2010 to February 2012. The variables analyzed subject characteristics, applied PMTCT program and risk factors affecting transmission. Result: Seventy-five pregnant women who were HIV-positive were initially recruited, but 21 subjects were excluded due to incomplete medical records. In the first group (n=27) who received complete PMTCT, no vertical transmission was identified, while in the second group (n=27) with incomplete PMTCT, seven children were found to be HIV-positive. Rupture of membrane for more than 4 hours was the only significant risk factor for vertical transmission (p=0.001, RR=64.5, 95% CI=6.14-677.6). Conclusion: There was a significant difference in the occurrence of vertical transmission between complete and incomplete PMTCT program. Complete PMTCT program may provide protective effect against the occurrence of vertical transmission by 25.9%. Keywords: HIV, PMTCT, vertical transmission

Placental Growth Factor Levels in Preeclampsia Compared to Normal Pregnancy Situmorang, Dumaria; Tendean, Hermie MM; Wantania, John J
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (110.677 KB)

Objective: To identify and analyze the differences in the levels of PlGF in preeclampsia and normal pregnancy. Method: This was a cross-sectional observational qualitative study of PlGF in preeclampsia and normal pregnancy. The number of samples in case and control group was 30 in each groups. Result: We found that mean of maternal age in the preeclampsia group was 28.53 years and 25.23 years in the control group. Mean parity in preeclampsia and control group was 2.33 and 1.56, respectively. Mean hemoglobin level in preeclampsia and control group was 11.97 and 11.99, respectively. Mean maternal blood glucose level was 87.0 in the preeclampsia group, and 87.9 in the control group. In the preeclampsia group mean urea concentration was 16.45, while it was 22.78 in the control group. Mean creatinine level was 0.92 in the preeclampsia group and 0.64 in the control group. Mean SGPT and SGOT in the preeclampsia group was 23.36 and 21.97, while in the control group was 29.86 and 26.20. Test results showed that PlGF levels was significantly different between the preeclampsia and control group. Mean PlGF in the preeclampsia and control group was 42.10 and 452.33 respectively, with p

Clinical Evaluation of Neoadjuvant Chemotherapy Followed by Radical Hysterectomy in the Management of Cervical Cancer Stage IIB Sanif, Rizal
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To evaluate the clinical efficacy, operability, radicality, toxicity, and incidence of recurrences of neoadjuvant chemotherapy (NAC) followed by radical hysterectomy (RH) among patients with stage IIB cervical cancer. Method: This is an observational clinical study at Dr. Moh. Hoesin Hospital, Palembang. Data were analyzed from 27 patients who matched the inclusion criteria and underwent 3 cycles of neoadjuvant chemotherapy (NAC) with Paclitaxel (75 mg/m2) in combination with Cisplatin (50 mg/m2) and Docetaxel (75 mg/m2) combined with Carboplatin (300 mg/m2) according to AUC 6, followed by radical hysterectomy from January 2012 until December 2013. Result: The operability rate after NAC was 96.4%. Lymph node metastases were negative in 75% of patients, and we found bilateral lymph node metastases in 14.3% of patients. Parametric infiltrations were negative in 85.7% of the patients, and positive in 14.3% of patients. No vaginal infiltrations were found. As much as 89.3% of the patients did not experience any side effect, while anemia and thrombocytopenia were found in 10.8% of the patients. We found that 7.1% of patients had recurrences within 6 months interval. Conclusion: NAC followed by radical hysterectomy showed significant advantages for patients with stage IIB cervical cancer, with fewer side effects. However, long-term evaluation and a larger number of patients are required to confirm this result. Keywords: cervical cancer, neoadjuvant chemotherapy, radical hysterectomy

User Profile and Factors Correlating to Duration of Intrauterine Device Use Gunardi, Eka R; Fadli, Fadli
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To determine the demographic and clinical profile of intrauterine device (IUD) users and factors correlating to duration of IUD use. Method: We conducted a prospective observational study of 867 patients who underwent IUD insertion in Raden Saleh Outpatient Clinic during the period of January - December 2011. All patients were followed for 1 year to ascertain any complaint of discharge after insertion. Spearman correlation test was conducted to inves- tigate the strength of correlation and significance between age, parity, and discharge, with duration of IUD use. Result: During year 2011, 867 patients (median of age=34 [range=14-49]; median parity=2 [range=0-7]) underwent IUD insertion in Raden Saleh Clinic. The majority of subjects were aged between 31-35 years old and were willing to use IUD for 4 years. Bivariate analysis revealed a significant correlation between age, parity, and vaginal discharge with duration of IUD use. The strongest correlation was identified between age and duration of use (r=0.25, p0.002 for parity and duration of use; r=0.05 p=0.045 for discharge and duration of use). Conclusion: Most IUD users were aged 31-35 years, who were willing to use IUD for 4 years. Factors that correlated with duration of IUD use were age, parity, and vaginal discharge. Keywords: contraceptive, duration of use, family planning, intrauterine device

Survival and Side Effects of Cisplatin/Cyclophosphamide and Carboplatin/Paclitaxel Adjuvant Chemotherapy in Stage IC-IV Ovarian Cancer Markus, Unedo H; Winarto, Hariyono; Andrijono, Andrijono; Sutrisna, Bambang
Indonesian Journal of Obstetrics and Gynecology Volume. 3, no. 2, April 2015
Publisher : Indonesian Socety of Obstetrics and Gynecology

Objective: To compare the survival and side effects in epithelial ovarian cancer patients receiving adjuvant chemotherapy of cisplatin/ cyclophosphamide and carboplatin/paclitaxel. Method: We recruited epithelial ovarian cancer patients receiving cisplatin/cyclophosphamide (group A) or carboplatin/paclitaxel (group B) adjuvant chemotherapy after surgery. Chemotherapy was given for six cycles. Overall survival and side effects were assessed. Result: A total of 49 patients were recruited, consisting of 25 patients for group A and 24 patients for group B. In this study, the overall survival of stage IC-IV ovarian cancer patients was 37.3 months in group A (95%CI=31.86-43.46) and 35.5 months (95%CI= 13.93- 43.46) in group B (p

Page 1 of 3 | Total Record : 21

1 2 3

Filter by Year

2015 2015

Filter By Issues

All Issue Volume 11 No. 4 October 2023 Volume 11 No. 3 July 2023 Volume 11 No. 2 April 2023 Volume 11 No. 1 January 2023 Volume 10 No. 4 Oktober 2022 Volume 10 No. 3 July 2022 Volume 10 No. 2 April 2022 Volume 10 No. 1 January 2022 Volume 9 No. 4 October 2021 Volume 9 No. 3 July 2021 Volume 9 No. 2 April 2021 Volume 9 No. 1 January 2021 Volume 8 No. 4 October 2020 Volume 8 No. 3 July 2020 Volume 8 No. 2 April 2020 Volume 8 No. 1 January 2020 Volume 7 No. 4 October 2019 Volume 7 No. 3 July 2019 Volume 7 No. 2 April 2019 Volume 7 No. 2 April 2019 Volume 7, No. 1 January 2019 Volume 7, No. 1 January 2019 Volume 6 No. 4 October 2018 Volume 6 No. 4 October 2018 Volume 6 No. 3 July 2018 Volume 6 No. 3 July 2018 Volume 6. No. 2 April 2018 Volume 6. No. 2 April 2018 Volume 6. No. 1. January 2018 Volume 6. No. 1. January 2018 Volume. 5, No. 4, October 2017 Volume. 5, No. 4, October 2017 Volume. 5, No. 3, July 2017 Volume. 5, No. 3, July 2017 Volume. 5, No. 2, April 2017 Volume. 5, No. 2, April 2017 Volume. 5, No. 1, January 2017 Volume. 5, No. 1, January 2017 Volume 4, No. 4, October 2016 Volume 4, No. 4, October 2016 Volume. 4, No.3, July 2016 Volume. 4, No.3, July 2016 Volume. 4, No. 2, April 2016 Volume. 4, No. 2, April 2016 Volume. 4, No. 1, January 2016 Volume. 4, No. 1, January 2016 Volume. 3, No. 4, October 2015 Volume. 3, No. 4, October 2015 Volume. 3, No. 3, July 2015 Volume. 3, No. 3, July 2015 Volume. 3, no. 2, April 2015 Volume. 3, no. 2, April 2015 Volume. 3, No. 1, January 2015 Volume. 3, No. 1, January 2015 Volume. 2, No. 4, October 2014 Volume. 2, No. 4, October 2014 Volume. 2, No. 3, July 2014 Volume. 2, No. 3, July 2014 Volume. 2, No. 2, April 2014 Volume. 2, No. 2, April 2014 Volume. 2, No. 1, January 2014 Volume. 2, No. 1, January 2014 Volume. 37, No. 2, April 2013 Volume. 37, No. 2, April 2013 Volume. 37, No. 1, January 2013 Volume 37, No. 1, January 2013 Volume 37, No. 1, January 2013 Volume. 1, No. 4, October 2013 Volume. 1, No. 4, October 2013 Volume. 1, No. 3, July 2013 Volume. 1, No. 3, July 2013 Volume. 36, No. 4, October 2012 Volume. 36, No. 4, October 2012 Volume. 36, No. 3, July 2012 Volume. 36, No. 3, July 2012 Volume. 36, No. 2, April 2012 Volume. 36, No. 2, April 2012 Volume. 36, No. 1, January 2012 Volume. 36, No. 1, January 2012 Volume. 35, No. 4, October 2011 Volume. 35, No. 4, October 2011 Volume. 35, No. 3, July 2011 Volume. 35, No. 3, July 2011 Volume. 35, No. 2, April 2011 Volume. 35, No. 2, April 2011 Volume. 35, No. 1, January 2011 Volume. 35, No. 1, January 2011 Volume. 34, No. 4, October 2010 Volume. 34, No. 4, October 2010 Volume. 34, No. 3, July 2010 Volume. 34, No. 3, July 2010 Volume. 34. No. 2, April 2010 Volume. 34. No. 2, April 2010 Volume. 34, No. 1, January 2010 Volume. 34, No. 1, January 2010 Volume. 33. No. 4, October 2009 Volume. 33. No. 4, October 2009 Volume. 33, No. 3, July 2009 Volume. 33, No. 3, July 2009 Volume. 33, No. 2, April 2009 Volume. 33, No. 2, April 2009 Volume. 33, No. 1, January 2009 Volume. 33, No. 1, January 2009 Volume. 32, No. 4, October 2008 Volume. 32, No. 4, October 2008 Volume. 32, No. 3, July 2008 Volume. 32, No. 3, July 2008 Volume. 32, No. 2, April 2008 Volume. 32, No. 2, April 2008 Volume. 32, No. 1, January 2008 Volume. 32, No. 1, January 2008 Volume. 31, No. 4, October 2007 Volume. 31, No. 4, October 2007 Volume. 31, No. 3, July 2007 Volume. 31, No. 3, July 2007 Volume. 31, No. 2, April 2007 Volume. 31, No. 2, April 2007 Volume. 31, No. 1, January 2007 Volume. 31, No. 1, January 2007 Volume. 30, No. 4, October 2006 Volume. 30, No. 4, October 2006 Volume. 30, No. 3, July 2006 Volume. 30, No. 3, July 2006 Volume. 30, No. 2, April 2006 Volume. 30, No. 2, April 2006 Volume. 30, No. 1, January 2006 Volume. 30, No. 1, January 2006 More Issue

Home Page

OAI Link

Editorial Team

Contact

Reviewer

Google Scholar

Contact Name
eko subaktiansyah

Contact Email
eko.subaktiansyah@gmail.com

Phone
-

Journal Mail Official
support@inajog.com

Editorial Address
-

Location
Kota adm. jakarta pusat,

Dki jakarta

INDONESIA

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Home Page

OAI Link

Editorial Team

Contact

Reviewer

Google Scholar

Contact Name eko subaktiansyah

Contact Email eko.subaktiansyah@gmail.com

Phone -

Journal Mail Official support@inajog.com

Editorial Address -

Location Kota adm. jakarta pusat, Dki jakarta INDONESIA

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Abstract

Contact Name
eko subaktiansyah

Contact Email
eko.subaktiansyah@gmail.com

Phone
-

Journal Mail Official
support@inajog.com

Editorial Address
-

Location
Kota adm. jakarta pusat,

Dki jakarta

INDONESIA